Factors associated to medicine use among children from the 2004 Pelotas Birth Cohort (Brazil)

OBJECTIVE: To identify factors associated to medicine use among children from the 2004 Pelotas Birth Cohort, Brazil. METHODS: Prospective study to evaluate medicine use in children aged 3, 12 and 24 months regardless of the reasons, therapeutic indication or class. The study included 3,985 children followed up at three months of age, 3,907 at 12 months, and 3,868 at the last follow-up time of 24 months. Mothers were interviewed to collect information on medicine use during the recall period of 15 days prior to the interview. The outcome was studied according to sociodemographic and perinatal variables, mother's perception of child's health and breastfeeding status. Crude and adjusted analyses were performed by Poisson regression following a hierarchical model. RESULTS: The prevalence of medicine use ranged from 55% to 65% in the three follow-ups. After controlling for confounders, some variables remained associated to medicine use only at the three-month follow-up with greatest use among children of younger mothers, those children who had intrapartum complications, low birthweight, were never breastfed and were admitted to a hospital. Greatest medicine use was also associated with being a firstborn child at 3 and 12 months; mother's perception of their child health as fair or poor and children whose mothers have private health insurance at 12 and 24 months; highest maternal education level at all follow-up times. CONCLUSIONS: Different variables influence medicine use among children during the first two years of life and they change as the child ages especially maternal factors and those associated to the child's health problems.

The importance to update the guidelines for the use of genetic testing in noncancer patients in Brazil

The Brazilian National Regulatory Agency for Private Health Insurance and Plans has recently published a technical note defining the criteria for the coverage of genetic testing to diagnose hereditary cancer. In this study we show the case of a patient with a breast lesion and an extensive history of cancer referred to a private service of genetic counseling. The patient met both criteria for hereditary breast and colorectal cancer syndrome screening. Her private insurance denied coverage for genetic testing because she lacks current or previous cancer diagnosis. After she appealed by lawsuit, the court was favorable and the test was performed using next-generation sequencing. A deletion of MLH1 exon 8 was found. We highlight the importance to offer genetic testing using multigene analysis for noncancer patients.

O impacto da variação do preço na procura de cuidados de saúde

RESUMO - Assiste-se a um crescimento exponencial das despesas em saúde, quer na Europa como nos Estados Unidos. Em Portugal, os gastos totais com a saúde ascenderam a 10,2% do PIB, em 2006, contra os 8,8% registados no início da década anterior. É importante perceber o que motiva este crescimento quer em termos globais, quer no que diz respeito ao consumo de recursos, bem como até em termos da despesa pública. Este projecto tem dois objectivos fundamentais: em primeiro lugar, contribuir para o estudo dos factores determinantes da procura de cuidados de saúde em Portugal e, consequentemente, determinar as elasticidades procura – preço para diferentes tipos de cuidados de saúde. Metodologia: Estudo observacional baseado na análise empírica de dados administrativos (claims) respeitantes à utilização dos cuidados de saúde por parte de 12.230 indivíduos detentores de um plano de seguro de saúde individual, numa seguradora privada em Portugal. As elasticidades procura – preço para os diferentes tipos de cuidados de saúde obtiveram-se utilizando as variações percentuais das quantidades dos diferentes cuidados de saúde, antes e depois da variação do preço pago pelo indivíduo, para cada tipo de cuidado de saúde. Resultados: De acordo com a teoria económica tradicional o aumento do preço a pagar reduz o consumo de cuidados de saúde, e a procura é elástica, ou seja, os valores da elasticidade procura – preço obtidos são superiores a 1, em valor absoluto, logo o aumento do preço levou a uma redução mais do que proporcional das quantidades procuradas. A procura de cuidados de saúde em ambulatório é mais sensível à variação do preço do que a procura de cuidados de internamento. ------- ABSTRACT - We are witnessing an exponential growth of health care expenditures around the world. In Portugal, the total expenditure on health amounted to 10.2% of GDP in 2006, against 8.8% at the beginning of previous decade. It is important to understand what motivates this growth both in overall terms, with respect to resource consumption, and even in terms of public spending. This study was designed two achieve two objectives: first, to contribute to the study of demand for health care and, more specifically, to analyze the effect of price changes on the utilization of health care services; and secondly, to estimate the demand elasticity for different types of heath care. Methodology: Observational study based on empirical analysis of administrative data (claims) from a private health insurance Company in Portugal. The sample used had information regarding 12.230 individuals. Demand elasticity for the different types of health care services was obtained by the quotient between the percentage changes in the quantity of health care services, before and after the change in the price paid by the corresponding percentage change in the price. Results: This study showed that, for all medical services, price increases were associated with reductions in the quantity of care consumed as predicted by neoclassical demand theory, and we are in the presence of an elastic demand. This means that price elasticity is greater than 1 in absolute value so the increase in the price led to a more than proportional reduction in the quantity demanded. Demand elasticity was more responsive to changes in the price of specialist and emergency care than to changes in the price of inpatient care.

Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective

BACKGROUND: The optimal length of stay (LOS) for patients with pulmonary embolism (PE) is unknown. Although reducing LOS is likely to save costs, the effects on patient safety are unclear. We sought to identify patient and hospital factors associated with LOS and assess whether LOS was associated with postdischarge mortality. METHODS: We evaluated patients discharged with a primary diagnosis of PE from 186 acute care hospitals in Pennsylvania (January 2000 through November 2002). We used discrete survival models to examine the association between (1) patient and hospital factors and the time to discharge and (2) LOS and postdischarge mortality within 30 days of presentation, adjusting for patient and hospital factors. RESULTS: Among 15 531 patient discharges with PE, the median LOS was 6 days, and postdischarge mortality rate was 3.3%. In multivariate analysis, patients from Philadelphia were less likely to be discharged on a given day (odds ratio [OR], 0.82; 95% confidence interval [CI], 0.73-0.93), as were black patients (OR, 0.88; 95% CI, 0.82-0.94).The odds of discharge decreased notably with greater patient severity of illness and in patients without private health insurance. Adjusted postdischarge mortality was significantly higher for patients with an LOS of 4 days or less (OR, 1.55; 95% CI, 1.21-2.00) relative to those with an LOS of 5 to 6 days. CONCLUSIONS: Several hospital and patient factors were independently associated with LOS. Patients with a very short LOS had greater postdischarge mortality relative to patients with a typical LOS, suggesting that physicians may inappropriately select patients with PE for early discharge who are at increased risk of complications

A regulamentação dos preços dos planos individuais de saúde

Aggregate price indices measure variations in nominal prices. In this paper, we compare the inflation rates of the general economy and those of the health sector and private health insurance market between 2001 and 2005, based on the indices of Departamento Intersindical de Estatística e Estudos Socioeconômicos, of Fundação Instituto de Pesquisas Econômicas, of Instituto Brasileiro de Geografia e Estatística and IPEADATA database, to the private health insurance readjustment applied by the National Private Health Insurance Agency (ANS). The health sector inflation rate was found stable and inferior to the general one, what would validate applying lower readjustments derived from official price indices.

A regulação no mercado de planos de saúde: a ação do consumidor e a estratégia da Agência Nacional de Saúde Suplementar - ANS

The scope of this dissertation is to assess the attitudes of subscribers to private health insurance schemes and the regulatory strategy of the Ancillary National Health Agency -- ANS in relation to their demands. The ancillary health market features various players, each with their own specific interests and priorities. Consequently, the ANS should strive to maintain the balance between the consumers, the economic intermediaries and the State, ensuring that the Agency's powers to establish norms, as well as to regulate and to supervise each be exercised independently. Many people contend that there are elements not currently incorporated into the current services of the ANS which could contribute to its regulatory strategy. This study was conducted from the standpoint of theories applied to State administration for structural analysis of the ANS and its strategies, in addition to a symbolic and rational approach for a better understanding of the consumers involved. A survey was conducted of existing records of the ANS, as well as data collected from direct observation. Analysis of the data obtained led to the conclusion that the consumer can become a close ally in the regulatory activity of the ANS, to the extent that the latter may acquire more in-depth knowledge of aspects contained in the demands of the former.

Análise do desempenho econômico-financeiro de operadoras de planos de saúde no mercado de saúde suplementar brasileiro

O mercado privado de planos de saúde tem sido marcado por aumento dos custos da assistência médica, ampliação da cobertura de procedimentos, restrições nos reajustes dos planos e aumento das garantias de solvência exigidas pela Agência Nacional de Saúde Suplementar (ANS), impactando o desempenho econômico-financeiro das operadoras de planos de saúde. A presente dissertação tem como objetivo analisar o desempenho econômico-financeiro de operadoras das modalidades autogestão, cooperativa médica, medicina de grupo e seguradora no período de 2001 a 2012. Foi utilizada uma base de dados operacionais e contábeis disponível na página eletrônica da ANS, com 5.775 observações, avaliando-se o desempenho econômico-financeiro por meio de cinco indicadores: Retorno sobre Ativos, Retorno Operacional sobre Ativos, Retorno sobre o Patrimônio Líquido, Liquidez Corrente e Sinistralidade. Dois modelos hierárquicos foram adotados para estimar os efeitos operadora, modalidade e porte no desempenho. Dentre estes, a pesquisa identificou que o efeito operadora é responsável pela maior parte da variabilidade explicada do desempenho. A investigação permitiu identificar as operadoras que apresentaram melhor desempenho no período, direcionando a realização futura de estudos qualitativos visando conhecer os principais fatores que explicam o desempenho superior.

Comparando a saúde no Brasil com os países da OCDE: explorando dados de saúde pública

A atenção à saúde da população no Brasil gera um grande volume de dados sobre os serviços de saúde prestados. O tratamento adequado destes dados com técnicas de acesso à grande massa de dados pode permitir a extração de informações importantes para um melhor conhecimento do setor saúde. Avaliar o desempenho dos sistemas de saúde através da utilização da massa de dados produzida tem sido uma tendência mundial, uma vez que vários países já mantêm programas de avaliação baseados em dados e indicadores. Neste contexto, A OCDE – Organização para Cooperação e Desenvolvimento Econômico, que é uma organização internacional que avalia as políticas econômicas de seus 34 países membros, possui uma publicação bienal, chamada Health at a Glance, que tem por objetivo fazer a comparação dos sistemas de saúde dos países membros da OCDE. Embora o Brasil não seja um membro, a OCDE procura incluí-lo no cálculo de alguns indicadores, quando os dados estão disponíveis, pois considera o Brasil como uma das maiores economias que não é um país membro. O presente estudo tem por objetivo propor e implementar, com base na metodologia da publicação Health at a Glance de 2015, o cálculo para o Brasil de 22 indicadores em saúde que compõem o domínio “utilização de serviços em saúde” da publicação da OCDE. Para isto foi feito um levantamento das principais bases de dados nacionais em saúde disponíveis que posteriormente foram capturadas, conforme necessidade, através de técnicas para acessar e tratar o grande volume de dados em saúde no Brasil. As bases de dados utilizadas são provenientes de três principais fontes remuneração: SUS, planos privados de saúde e outras fontes de remuneração como, por exemplo, planos públicos de saúde, DPVAT e particular. A realização deste trabalho permitiu verificar que os dados em saúde disponíveis publicamente no Brasil podem ser usados na avaliação do desempenho do sistema de saúde, e além de incluir o Brasil no benchmark internacional dos países da OCDE nestes 22 indicadores, promoveu a comparação destes indicadores entre o setor público de saúde do Brasil, o SUS, e o setor de planos privados de saúde, a chamada saúde suplementar. Além disso, também foi possível comparar os indicadores calculados para o SUS para cada UF, demonstrando assim as diferenças na prestação de serviços de saúde nos estados do Brasil para o setor público. A análise dos resultados demonstrou que, em geral, o Brasil comparado com os países da OCDE apresenta um desempenho abaixo da média dos demais países, o que indica necessidade de esforços para atingir um nível mais alto na prestação de serviços em saúde que estão no âmbito de avaliação dos indicadores calculados. Quando segmentado entre SUS e saúde suplementar, a análise dos resultados dos indicadores do Brasil aponta para uma aproximação do desempenho do setor de saúde suplementar em relação à média dos demais países da OCDE, e por outro lado um distanciamento do SUS em relação a esta média. Isto evidencia a diferença no nível de prestação de serviços dentro do Brasil entre o SUS e a saúde suplementar. Por fim, como proposta de melhoria na qualidade dos resultados obtidos neste estudo sugere-se o uso da base de dados do TISS/ANS para as informações provenientes do setor de saúde suplementar, uma vez que o TISS reflete toda a troca de informações entre os prestadores de serviços de saúde e as operadoras de planos privados de saúde para fins de pagamento dos serviços prestados.

Caminhos da política de saúde no Brasil: determinantes da “universalização excludente” em curso

O interesse deste estudo foi, de modo geral, poder identificar como o modelo privatista influenciou as ações da política pública de saúde no Brasil, como se deram os impactos da política macroeconômica neste sentido. Um dos pontos chave a ser verificado gira em torno da desigualdade de acesso da população ao serviço de saúde, com a não concretização da universalidade, gerando um processo denominado “universalização excludente”. Esse processo que consiste na migração de usuários do SUS para as operadoras de planos de saúde privados contribui para a mudança da racionalidade da saúde como direito para a racionalidade da eficiência, a racionalidade burguesa. Parte-se do referencial da Reforma Sanitária brasileira, como um marco da luta dos movimentos sociais pela democratização no país e como ponto inicial do reconhecimento da saúde enquanto direito de todos e dever do Estado, buscando fazer um resgate histórico deste movimento. Tem, ainda, como referência o pressuposto da minimização da atuação do Estado no trato às políticas sociais e a interferência direta de grandes organismos financeiros internacionais na condução do modo de fazer política de saúde, a exemplo do Banco Mundial. Esta consiste em uma pesquisa qualitativa, de cunho teórico, com o objetivo de proporcionar subsídios para a discussão do tema da política de saúde no Brasil, bem como promover e ampliar o debate teórico acerca da função que o Estado desempenha no modo de pensar e executar essa política.

Contextual and individual inequalities in dental pain prevalence among Brazilian adults and elders

This study aimed to assess the prevalence of dental pain among adults and older people living in Brazil's State capitals. Information was gathered from the Telephone Survey Surveillance System for Risk and Protective Factors for Chronic Diseases (VIGITEL) in 2009 (n = 54,367). Dental pain was the outcome. Geographic region, age, gender, race, schooling, private health coverage, smoking, and soft drink consumption were the explanatory variables. Multilevel Poisson regression models were performed. Prevalence of dental pain was 15.2%; Macapa and Sao Luis had prevalence rates greater than 20%; all capitals in the South and Southeast, plus Cuiaba, Campo Grande, Maceio, Recife, and Natal had prevalence rates less than 15%. Factors associated with increased prevalence of dental pain were the North and Northeast regions, female gender, black/brown skin color, lack of private health insurance, smoking, and soft drink consumption. Dental pain is a public health problem that should be monitored by health surveillance systems.

Barriers to Timely Screening Colonoscopy

Objective: Colorectal cancer (CRC) can be largely prevented or effectively treated in its early stages, yet disparities exist in timely screening. The aim of this study was to explore the disparities in CRC screening on the basis of health insurance status including private, Medicare, Medicaid, and State Administered General Assistance (SAGA). Methods: A retrospective chart review for the period January 2000 to May 2007 (95 records) was conducted at two clinic sites; a private clinic and a university hospital clinic. All individuals at these sites who met study criteria (>50 years old with screening colonoscopy) were included. Age, gender, date of first clinic visit when screening referral was made, and date of completed procedure (screening colonoscopy) were recorded. Groups were dichotomized between individuals with private health insurance and individuals with public health insurance. Individuals with any history of CRC, known pre-cancerous conditions as well as family history of CRC requiring frequent colonoscopy were excluded from the study. Linear model analysis was performed to compare the average waiting time to receiving screening colonoscopy between the groups. T-test was performed to analyze age or gender related differences between the two groups as well as within each group. Results: The average waiting time (33 days) for screening colonoscopy in privately insured individuals was significantly lower than publicly insured individuals (200 days). The time difference between the first clinic visit and the procedure was statistically significant (p < 0.0001) between the two groups. There was no statistical difference (p=0.089) in gender between these groups (public vs. private). There were also no statistically significant gender or age related differences found within each group. Conclusions: Disparities exist in timely screening for CRC and one of the barriers leading to delayed CRC screening includes health insurance status of an individual. Even within the insured group, type of insurance plays major role. There is a negative correlation between public health insurance status and timely screening. Differences in access to medical care and delivery of care experienced by patients who are publicly insured through Medicaid, Medicare, and SAGA, suggests that the State of Connecticut needs to implement changes in health care policies that would provide timely screening colonoscopy. It is evident that health insurance coverage facilitates timely access to healthcare. Therefore, there is a need for increased efforts in advocacy for policy, payment and physician participation in public insurance programs. A state-wide comprehensive program involving multiple components targeting different levels of change such as provider, patients and the community should help reduce some of the observed causes of healthcare disparities based on the insurance status.

PREVALENCE AND FACTORS ASSOCIATED WITH THE PERFORMANCE OF MAMMOGRAPHY AND PAP SMEAR TEST

Objective: To estimate the prevalence and factors associated with the performance of mammography and pap smear test in women from the city of Maringá, Paraná. Methods: Population-based cross-sectional study conducted with 345 women aged over 20 years in the period from March 2011 to April 2012. An interview was carried out using a questionnaire proposed by the Ministry of Health, which addressed sociodemographic characteristics, risk factors for chronic noncommunicable diseases and issues related to mammographic and pap screening. Data were analyzed using bivariate analysis, crude analysis with odds ratio (OR) and chi-squared test using Epi Info 3.5.1 program; multivariate analysis using logistic regression was performed using the software Statistica 7.1, with a significance level of 5% and a confidence interval of 95%. Results: The mean age of the women was 52.19 (±5.27) years. The majority (56.5%) had from 0 to 8 years of education. Additionally, 84.6% (n=266) of the women underwent pap smear and 74.3% (n=169) underwent mammography. The lower performance of pap smear test was associated with women with 9-11 years of education (p=0.01), and the lower performance of mammography was associated with women without private health insurance (p<0.01). Conclusion: The coverage of mammography and pap smear test was satisfactory among the women from Maringá, Paraná. Low education level and women who depended on the public health system presented lower performance of mammography.

Dental set-vice provision in private general practice for an insured population in New South Wales, Australia

Objective To determine patterns of dental set-vices provided to a cohort of the insured population 18 years and over, in private general practice in New South Wales, Australia. Basic research design A cohort study using the person-years method and Poisson regression for analysis. Setting Data were derived from claims records submitted by members of a health insurance fund (Government Employees Health Fund-GEHF) for rebates during the study period 1 January 1992-31 December 1995. Participants There were 133,467 members aged 18 years and over from New South Wales. Main outcome measures To determine, by age group, for those members who used private general practice and made a claim (referred to as 'patients') the annual number of visits, total number of services received per year and number of services received at a visit, Results The mean number of visits per patient was 2.4 per year with patients under 45 years making fewer visits than the 45-54 age group reference category. Mean number of services utilised per patient-year was 5.9, with services provided increasing from 3.5 for the 18-24-year-old group, reaching a plateau of approximately 6.2 for those aged 45 years or more. The number of services received per visit was 2.4 and there were no differences by age. Service mix was dominated by restorative (35%), diagnostic (27%), and preventive services (18%); with age specific variations observed. Conclusions Age was found to be an important determinant in the use of dental services, independent of membership duration and gender.

Health technology diffusion in developing countries: a case study of CT scanners in Brazil

Background The development of products and services for health care systems is one of the most important phenomena to have occurred in the field of health care over the last 50 years. It generates significant commercial, medical and social results. Although much has been done to understand how health technologies are adopted and regulated in developed countries, little attention has been paid to the situation in low- and middle-income countries (LMICs). Here we examine the institutional environment in which decisions are made regarding the adoption of expensive medical devices into the Brazilian health care system. Methods We used a case study strategy to address our research question. The empirical work relied on in-depth interviews (N = 16) with representatives of a wide range of actors and stakeholders that participate in the process of diffusion of CT (computerized tomography) scanners in Brazil, including manufacturers, health care organizations, medical specialty societies, health insurance companies, regulatory agencies and the Ministry of Health. Results The adoption of CT scanners is not determined by health policy makers or third-party payers of public and private sectors. Instead, decisions are primarily made by administrators of individual hospitals and clinics, strongly influenced by both physicians and sales representatives of the medical industry who act as change agents. Because this process is not properly regulated by public authorities, health care organizations are free to decide whether, when and how they will adopt a particular technology. Conclusions Our study identifies problems in how health care systems in LMICs adopt new, expensive medical technologies, and suggests that a set of innovative approaches and policy instruments are needed in order to balance the institutional and professional desire to practise a modern and expensive medicine in a context of health inequalities and basic health needs.

Double coverage and demand for health care: Evidence from quantile regression

An individual experiences double coverage when he bene ts from more than one health insurance plan at the same time. This paper examines the impact of such supplementary insurance on the demand for health care services. Its novelty is that within the context of count data modelling and without imposing restrictive parametric assumptions, the analysis is carried out for di¤erent points of the conditional distribution, not only for its mean location. Results indicate that moral hazard is present across the whole outcome distribution for both public and private second layers of health insurance coverage but with greater magnitude in the latter group. By looking at di¤erent points we unveil that stronger double coverage e¤ects are smaller for high levels of usage. We use data for Portugal, taking advantage of particular features of the public and private protection schemes on top of the statutory National Health Service. By exploring the last Portuguese Health Survey, we were able to evaluate their impacts on the consumption of doctor visi